$13MVenture, 20 January 2026
New round from existing and new investors to advance AI-driven medication adherence.
- Amount
- $13M
- Stage
- Venture
- Announced
- 20 January 2026
- Lead
- Eclipse
- Other investors
- General Catalyst, Insight Partners, Mayo Clinic, New Leaf Venture Partners
- Use of funds
- New round from existing and new investors to advance AI-driven medication adherence.
- Checked
- Announced by the company
- Sources
- BrightInsight closes $13M for AI medication adherence platform vcnewsdaily.com
BrightInsight closes $13M for AI medication adherence platform pulse2.com